Cytokinetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO

Robert I. Blum

CEORobert I. Blum

Employees

498

Employees498

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1997

Founded1997

Employees

498

Employees498

CYTK Key Statistics

Market cap

3.88B

Market cap3.88B

Price-Earnings ratio

-6.11

Price-Earnings ratio-6.11

Dividend yield

—

Dividend yield—

Average volume

1.48M

Average volume1.48M

High today

$33.17

High today$33.17

Low today

$32.07

Low today$32.07

Open price

$32.81

Open price$32.81

Volume

2.32M

Volume2.32M

52 Week high

$61.38

52 Week high$61.38

52 Week low

$29.31

52 Week low$29.31

CYTK News

Investing.com 5d

Cytokinetics CEO Robert Blum sells $169,000 in stock - Investing.com

...

Analyst ratings

86%

of 22 ratings

Buy

86.4%

Hold

13.6%

Sell

People also own

Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.